Human papillomavirus disease in GATA2 deficiency: a genetic predisposition to HPV-associated female anogenital malignancy.

MLA

Dancy, Ehren, et al. “Human Papillomavirus Disease in GATA2 Deficiency: A Genetic Predisposition to HPV-Associated Female Anogenital Malignancy.” Frontiers in Immunology, Sept. 2024, pp. 1–10. EBSCOhost, https://doi.org/10.3389/fimmu.2024.1445711.

APA

Dancy, E., Stratton, P., Pichard, D. C., Marciano, B. E., Cowen, E. W., McBride, A. A., Van Doorslaer, K., Merideth, M. A., Salmeri, N., Hughes, M. S., Heller, T., Parta, M., Hickstein, D. D., Kong, H. H., Holland, S. M., & Zerbe, C. S. (2024). Human papillomavirus disease in GATA2 deficiency: a genetic predisposition to HPV-associated female anogenital malignancy. Frontiers in Immunology, 1–10. https://doi.org/10.3389/fimmu.2024.1445711

Chicago

Dancy, Ehren, Pamela Stratton, Dominique C. Pichard, Beatriz E. Marciano, Edward W. Cowen, Alison A. McBride, Koenraad Van Doorslaer, et al. 2024. “Human Papillomavirus Disease in GATA2 Deficiency: A Genetic Predisposition to HPV-Associated Female Anogenital Malignancy.” Frontiers in Immunology, September, 1–10. doi:10.3389/fimmu.2024.1445711.